Eton Pharmaceuticals
Sean Brynjelsen is currently the CEO and Director at Eton Pharmaceuticals. Sean has over 25 years of experience in the pharmaceutical industry. Sean started their career at Baxter Healthcare in 1995 as a Manager. Sean then moved to Hospira in 2005 as a Senior Program Manager. In 2007, they joined Akorn as Vice President of New Business Development and R&D. Sean was promoted to Senior Vice President, Global Business Development in 2014. Sean left Akorn in 2016 to join Sagent Pharmaceuticals as Executive Vice President Business Development. Sean held this position until June 2017 when they joined Eton Pharmaceuticals.
Sean Brynjelsen has a Master in Business Administration from the University of Notre Dame - Mendoza College of Business, a MS in Chemistry from the University of Illinois Chicago, and a BS in Biochemistry from the University of Illinois Chicago.
Bharathi Devarakonda - SVP, Regulatory Affairs & Technical Services, Paul Stickler - SVP, Commercial, and Wilson Troutman - Chief Financial Officer report to Sean Brynjelsen.
This person is not in any offices
Eton Pharmaceuticals
Eton Pharmaceuticals is a Deer Park, Illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the U.S Food and Drug Administration’s 505(b)(2) regulatory pathway.